Anthropic CEO Defends Safety via Tech Leadership

Amodei argues leading AI development elevates industry standards despite criticism over accelerated projects

Dario Amodei, Anthropic's CEO who has advocated for slowing the pace of artificial intelligence (AI) development, has rebutted criticism that the company's massive investments and accelerated development contradict its safety principles. He argued that companies developing technology safely must lead in cutting-edge competition to raise industry-wide safety standards. By emphasizing safety as the reason to both slow AI development and maintain a competitive edge, Amodei framed safety as the core justification for Anthropic's strategy.

Amodei posted on social media X on October 20, local time, stating, "Our strategy has always been a 'race to the top,'" adding, "By demonstrating responsible technology development, we can elevate industry standards." He emphasized, "The impact is far greater when the company executing this is at the forefront of technology." The logic is that if safety-focused firms lead technologically, others will follow.

The post was a response to criticism from Nathan Calvin, Chief Strategy Officer (CSO) of AI safety nonprofit EncodeAI. In September, Amodei had proposed slowing the improvement of AI model capabilities. However, Calvin highlighted nine instances where Anthropic allegedly accelerated AI development despite its safety stance, including a contract securing over 500 billion dollars in computing resources and increased use of its AI, Claude, in next-generation model development. Calvin argued that Anthropic prioritizes accelerating AI development while publicly emphasizing safety.

Amodei also claimed Anthropic sacrificed business interests for safety. He noted that while the company secured a Mythos-class model in February, it delayed its public release until June to strengthen cybersecurity measures. "Economically, releasing the model immediately would have been far more rational," he said, adding, "We likely sacrificed a significant portion of our model's lead over several months." He acknowledged that strict restrictions to prevent biological weapon misuse have caused the company to miss out on legitimate biological research demand but stated, "It's the right thing to do, and we will continue."

Amodei did not retract the need for slowing development entirely. Regarding the challenge of safety measures lagging behind AI acceleration, he said, "We are nearing that point, which is driving discussions about 'speed moderation.'" However, he did not specify when or by how much Anthropic would slow its development.

The debate emerged as Anthropic prepares for a large-scale initial public offering (IPO). The company is expected to list next month with a valuation of 2 trillion dollars. It recently announced third-quarter revenue of 16.8 billion dollars.